Skip to main content
David Mason Jr, MD, Internal Medicine, Marietta, GA

DavidHoutMasonJrMD

Internal Medicine Marietta, GA

Chief Medical Officer MiMedx Group Inc

Dr. Mason is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Mason's full profile

Already have an account?

  • Office

    3615 Paper Mill Rd SE
    Marietta, GA 30067
    Phone+1 770-956-3722

Summary

  • Dr. David Mason is an internist in Marietta, GA, with subspecialties in rheumatology and infectious diseases. He received his medical degree from Duke University School of Medicine, taught at the University of Michigan, was in practice for 8 years, and has been working in the pharmaceutical, device and biotech industries for 37 years. He is experienced in rheumatoid arthritis, arthritis, and clinical trials in multiple indications. He has led the development of more than fifteen drugs and devices. He has more than 20 publications and over 200 citings.

Education & Training

  • University of Michigan
    University of MichiganResidency, Internal Medicine, 1976 - 1977
  • Duke University Hospital
    Duke University HospitalInternship, Internal Medicine, 1973 - 1974
  • Duke University School of Medicine
    Duke University School of MedicineClass of 1973
  • Williams College
    Williams CollegeB.A., Chemistry, Magna Cum Laude, 1965 - 1969

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2008 - 2025
  • NC State Medical License
    NC State Medical License 1979 - 2025
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Mosby Award, Class President Duke Medical School, 1973
  • Phi Beta Kappa Junior Year, Williams College
  • Alpha Omega Alpha Honorary Medical Society, Junior Year Duke University Medical School
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study A randomized controlled trial  
    Smolen, J., Landewe, R.B., Mease, P., Brzezicki, J., Mason, D., Luijtens, K., van Vollenhoven, R.F., Kavanaugh, A., Schiff, M., Burmester, G.R., Strand, V., Vencovsky,..., Ann Rheum Dis, 11/1/2008
  • Certolizumab Pegol Plus Methotrexate Is Significantly More Effective Than Placebo Plus Methotrexate in Active Rheumatoid Arthritis  
    Keystone, E., van der Heijde, D, Mason, Jr, D, Landewe, R, van Vollenhover, r, Combe, B, Emery, P, Strand, V, Mease, P, Desai, C., and Pavelka, K., Arthritis and Rheumatism, 11/1/2008
  • Certolizumab Pegol for the Treatment of Crohn’s Disease  
    Sandborn, W.J., Feagan, B.G., Stoinov, S., Honiball, P.J., Rutgeerts, P, Mason, D, Bloomfield, R, Schreiber, S, NEJM, 7/1/2007
  • Join now to see all